FCB-CHOPS: An Evolution of a Commonly Used Acronym for Evaluating Radiation Treatment Plans
- PMID: 40017913
- PMCID: PMC11867132
- DOI: 10.1016/j.adro.2024.101627
FCB-CHOPS: An Evolution of a Commonly Used Acronym for Evaluating Radiation Treatment Plans
Abstract
Checklists have been used across many fields as a systematic framework to reduce human error and improve safety. In radiation oncology, the CB-CHOP acronym was previously developed as a tool to aid physicians in assessing the quality of radiation treatment plans for approval. This manuscript updates the acronym for the modern era with the addition of F and S to create FCB-CHOPS: fusion, contours, beams, coverage, heterogeneity, organs at risk, prescription, and dose summation. These 2 additions reflect the evolution and importance of image fusion to aid in the delineation of targets and organs at risk and dose summation to reflect the increased incidence of reirradiation and the need to consider prior treatment courses in the final plan evaluation. Utilization of this and similar checklists is critical in maintaining high-quality and safe radiation oncology treatments.
© 2024 The Author(s).
Conflict of interest statement
Shearwood McClelland serves as a consultant for Gilmartin Capital (a company that evaluates surgically targeted radiation therapies), receives travel funding from GT Medical Technologies Inc, and receives research funding from the University Hospitals Minority Faculty Career Development Award, the ASTRO Emerging Investigator Award, the Robert Winn Diversity in Clinical Trials Career Development Award, the Case Comprehensive Cancer Center Accelerator Pilot Project Award, and the National Cancer Institute Paul Calabresi K12 Clinical Oncology Research Career Development Program. Daniel W. Golden receives grants or contracts from the National Institutes of Health, the Radiation Oncology Institute, and the Bucksbaum Institute for Clinical Excellence. He also is the chairman of the executive board for the Radiation Oncology Education Collaborative Study Group and is the manager for RadOncQuestions LCC. Raymond Mak receives grants or contracts from ViewRay, and acts as a consultant for ViewRay, AstraZeneca, Sio Capital Management, and Varian Medical Systems. He has also received honoraria from Novartis. Kevin Shiue reports article publishing charges was provided by Indiana University School of Medicine. All other authors (M.W., N.A., R.B.J., R.Y., E.F., O.I., and J.A.H.) have no disclosures.
Figures
References
-
- Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491–499. - PubMed
-
- Pawlicki T, Smith B, Hayman JA, Ford E. Safety is No Accident: A Framework for Quality Radiation Oncology Care. American Society for Radiation Oncology; 2019. Accessed 11 October 2022.https://www.astro.org/Patient-Care-and-Research/Patient-Safety/Safety-is...; https://mydigitalpublication.com/publication/?i=574416
-
- Dean M, Jimenez R, Mellon E, Fields E, Yechieli R, Mak R. CB-CHOP: A simple acronym for evaluating a radiation treatment plan. Appl Rad Oncol. 2017;6:28–30.
-
- Paganelli C, Meschini G, Molinelli S, Riboldi M, Baroni G. Patient-specific validation of deformable image registration in radiation therapy: overview and caveats. Med Phys. 2018;45:e908–e922. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials